ArticleFrontiers in cardiovascular medicine2022

Bivalirudin Presents a Favorable Safety Profile Regarding Adverse Drug Reactions, Thrombocytopenia, and Bleeding in Chinese Patients With High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Prospective, Multi-Center, Intensive Monitoring Study.

Xiaoping Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.